Home » Angiotech Announces Additional Diameters of Sutures to Further Expand Its Quill SRS PDO Product Line
Angiotech Announces Additional Diameters of Sutures to Further Expand Its Quill SRS PDO Product Line
Angiotech Pharmaceuticals, Inc., a global specialty pharmaceutical and medical device company, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to begin marketing additional diameters of its Quill Self-Retaining System (SRS) Polydioxanone (PDO) product line.
CNN
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May